BioHarvest Sciences Research and Development Expenses 2020-2024 | BHST

BioHarvest Sciences research and development expenses from 2020 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
BioHarvest Sciences Annual Research and Development Expenses
(Millions of US $)
2023 $3
2022 $2
2021 $4
2020 $1
2019 $1
2019 $1
2018 $1
BioHarvest Sciences Quarterly Research and Development Expenses
(Millions of US $)
2024-06-30 $1
2024-03-31 $1
2023-12-31 $1
2023-09-30 $1
2023-06-30 $1
2023-03-31 $1
2022-12-31 $1
2022-09-30 $1
2022-06-30 $0
2022-03-31 $1
2021-12-31 $2
2021-09-30 $1
2021-06-30 $1
2021-03-31 $1
2020-12-31 $0
2020-09-30 $0
2020-06-30 $0
2020-03-31 $0
2019-12-31
2019-09-30 $0
2019-06-30 $0
2019-03-31
Sector Industry Market Cap Revenue
Medical MED-BIOMED/GENE $0.098B $0.013B
BioHarvest Sciences Inc. is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications. BioHarvest Sciences Inc. is based in Vancouver, Canada.
Stock Name Country Market Cap PE Ratio
Primo Water (PRMB) United States $4.535B 35.81
P.A.M Transportation Services (PAMT) United States $0.430B 0.00
Rigetti Computing (RGTI) United States $0.325B 0.00
Alpha Cognition (ACOG) Canada $0.035B 0.00
Atlantic Coastal Acquisition II (ABP) United States $0.000B 0.00